RSPH9 Inhibitors
Chemical inhibitors of RSPH9 disrupt its function through various mechanisms affecting ciliary structure and function. Niclosamide compromises the energy supply required for ciliary movement by inhibiting oxidative phosphorylation, which is essential for maintaining the ciliary beat frequency. Similarly, Oligomycin A targets the mitochondrial ATP synthase, reducing ATP levels and thereby depriving cilia of the energy necessary for their motility. Chloroquine alters the endosomal pH, interfering with the post-translational modifications of ciliary proteins such as RSPH9, which can lead to improper localization and function within the cilia. Vanadate's inhibition of phosphatases can affect the phosphorylation states of proteins, altering signaling pathways and thereby influencing RSPH9's role in ciliary structure and movement.
Colchicine and Demecolcine both target microtubule dynamics but through different mechanisms; Colchicine disrupts microtubule polymerization, while Demecolcine causes microtubule depolymerization. Both actions lead to a compromised ciliary structure, which is necessary for RSPH9's function. Conversely, Paclitaxel stabilizes microtubules excessively, which can also impair the dynamic nature of cilia microtubules and disrupt the function of RSPH9. Cytochalasin D and Latrunculin A inhibit actin polymerization, which is crucial for ciliary protein trafficking. This inhibition can prevent RSPH9 from reaching the cilia, impeding its function. Brefeldin A disrupts vesicle trafficking by altering the Golgi apparatus, hindering the proper delivery of RSPH9 to the cilia. Monensin, by altering ionic gradients, can affect the localization and function of RSPH9 within the cilia. Each of these inhibitors, through their distinct actions, can disrupt the normal function of RSPH9 within the cilia, affecting ciliary movement and integrity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide is known as an antihelminthic drug that inhibits oxidative phosphorylation. RSPH9 is implicated in ciliary function, and inhibiting the energy supply through oxidative phosphorylation can lead to impaired ciliary beat frequency, thereby functionally inhibiting RSPH9's role in maintaining effective ciliary movement. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises endosomal pH, which can disrupt the post-translational modifications necessary for ciliary proteins like RSPH9 to function properly. This disruption can impede the correct localization and function of RSPH9 within the ciliary axoneme structure. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine disrupts microtubule polymerization. Since RSPH9 is associated with the microtubules of the cilia, colchicine can lead to the disassembly of ciliary microtubules, impairing the structural integrity required for RSPH9's function in cilia. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their disassembly. Excessive stabilization can disrupt the dynamic nature of cilia microtubules, thus indirectly inhibiting RSPH9 by preventing proper ciliary beat and function. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D inhibits actin polymerization. Ciliary function relies on the actin cytoskeleton for vesicle movement and positioning, which is essential for delivering proteins like RSPH9 to the cilia. This inhibitor can interfere with RSPH9's localization to the cilia, thus hindering its function. | ||||||
Colcemid | 477-30-5 | sc-202550A sc-202550 sc-202550B sc-202550C sc-202550D sc-202550E | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg | $68.00 $162.00 $318.00 $947.00 $1893.00 $6840.00 | 7 | |
Demecolcine, a microtubule depolymerizing agent, can disrupt the proper assembly of ciliary microtubules, indirectly inhibiting RSPH9 by impairing the ciliary structure necessary for its function. This can lead to defective ciliary motility, where RSPH9 plays a role. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Oligomycin A is an inhibitor of the mitochondrial ATP synthase. By reducing ATP levels, it can indirectly inhibit RSPH9 by depriving cilia of the energy required for their motility and maintenance, processes in which RSPH9 is involved. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts ionic gradients across membranes. By perturbing ionic homeostasis, monensin can affect the trafficking and localization of RSPH9 to the cilia, thereby inhibiting its function in ciliary motion. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers and inhibits polymerization. By disrupting the actin cytoskeleton, it can interfere with intracellular transport processes, including the delivery of RSPH9 to the cilia, which is essential for its functional role in ciliary movement. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the structure and function of the Golgi apparatus, inhibiting vesicle trafficking. This can prevent the proper trafficking of RSPH9 to the cilia and thus inhibit its function in maintaining normal ciliary structure and movement. | ||||||